/PRNewswire/ The Insight Partners published latest research study on "Diabetes Therapeutics Market Size, Share, Revenue, Growth Strategy, Industry Trends.
Exclusive content, features, opinions and comment - hand-picked by our editors, just for you.
Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
Track the industry of your choice with a daily newsletter specific to that industry.
Stay on top of your investments. Track stock prices in your portfolio.
NOTE :
The monthly duration product is an auto renewal based product. Once subscribed, subject to your card issuer s permission we will charge your card/ payment instrument each month automatically and renew your subscription.
In the Annual duration product we offer both an auto renewal based product and a non auto renewal based product.
Monday blues: Second Covid-19 wave stings indices as markets drop 1.8% The worsening coronavirus crisis triggered yet another sell-off in the domestic stock market on Monday, with the benchmark indices dropping more than 3 per cent before recouping some of the losses. A sharp jump in Covid-19 cases and fresh curbs to contain the spread of the virus have stoked concerns about the revival of the economy and corporate earnings, prompting some investors to pull back.
Delhi under lockdown for a week as rising Covid cases stretch health infra With more than 25,000 daily Covid cases stretching Delhi’s health infrastructure to its limit, patients gasping for oxygen, and bed occupancy running full, the national capital went into a week-long lockdown, starting 10 pm on Monday until 5 am on April 26. Meanwhile, the high court in Telangana gave a two-day ultimatum to the state government to decide on a lockdown or curfew.
Read more about Mankind Pharma may partner RDIF for Russian Covid-19 vaccine Sputnik V on Business Standard. According to sources close to the development, talks are in advanced stages between Mankind Pharma and RDIF